KON symposium recognizes early-career researchers in oncology

Leukemia research in Kiel took center stage at this year’s Kiel Oncology Network (KON) Young Investigator Awards, with four out of five researchers working on acute lymphoblastic leukemia (ALL) among those recognized at the “Young Researchers in Oncology” symposium in Kiel on 6 November 2026.

The symposium was organized by KON within the University Cancer Center Schleswig-Holstein (UCCSH). It brought together early-career researchers and graduates of the Oncology Certificate Program to present their work.

All four leukemia-associated award recipients work on projects within or associated with CATCH ALL, the DFG-funded clinical research unit now in its second funding period. Their research ranges from addressing molecular features of ALL to approaches to its diagnosis and treatment.

CATCH ALL speaker Claudia Baldus together with ALL researchers and KON Young Researchers Awardees Maja Kowol, Denis Pinkle and Miriam Kelm (from left to right). ALL researcher Christoph Hahn completed the Oncology Certificate program (on the right). Not in the photo: KON-awardee Sonja Bendig.
CATCH ALL speaker Claudia Baldus together with ALL researchers and KON Young Researchers Awardees Maja Kowol, Denis Pinkle and Miriam Kelm (from left to right). ALL researcher Christoph Hahn completed the Oncology Certificate program (on the right). Not in the photo: KON-awardee Sonja Bendig.

Alongside the awards, several young physicians and medical students, working in leukemia research, received certificates for completing the Oncology Certificate Program.

We congratulate the award recipients and program graduates on their achievements and thank Susanne Sebens and the KON for bringing early-career researchers together to present and discuss their work.

About CATCH ALL

The DFG-funded Clinical Research Unit (CRU) 5010 CATCH ALL brings together clinicians and basic scientists at the University Medical Center Schleswig-Holstein (UKSH) and Kiel University (CAU), within the University Cancer Center Schleswig-Holstein (UCCSH) and the Kiel Oncology Network (KON). The CRU combines clinical and molecular data from children and adults with acute lymphoblastic leukemia to investigate the molecular and immunological mechanisms that enable leukemia to persist despite treatment. Its goal is to inform the development of more precise therapeutic approaches, including T-cell and antibody-based strategies.

Find more details in the Kiel University press release (in German) here. 

Disclaimer: AI has been used for editing purposes.

Participating Institutes